Methanabol Tablets
Methanabol 10 British Dragon — Overview
Methanabol 10 Tablets deliver methandienone at 10 mg per tablet — the most granular dose format British Dragon offers for one of the most widely used oral anabolic steroids ever produced. Methandienone, commonly known as Dianabol, was developed in the late 1950s and became the foundational oral AAS for mass and strength protocols over the following decades. Its pharmacological profile is straightforward and potent: strong anabolic and androgenic activity, fast onset, significant nitrogen retention, and pronounced glycogenolysis — all producing rapid gains in muscle mass and strength within the first two weeks of use.
The 10 mg format's specific advantage is dose control. Where Methanabol 50 delivers a single indivisible 50 mg unit and Methanabol 20 steps in 20 mg increments, the 10 mg tablet allows users to dial in any dose from 10 to 100+ mg in 10 mg steps — useful for entry-level users starting at 20–30 mg, for experienced users fine-tuning their dose around side effects, and for protocols where precise daily dose management is a priority. Steroid Warehouse carries all three Methanabol formats to cover the full range of use cases.
About the Compound
Methandienone is a 17α-methylated derivative of testosterone with an additional 1,2-double bond in the A-ring (making it also a derivative of boldenone). The 17α-methyl group enables oral bioavailability by protecting the molecule from first-pass hepatic degradation, while simultaneously making the compound hepatotoxic — the liver enzyme elevation associated with all 17α-alkylated orals applies fully to methandienone. The 1,2-double bond reduces the compound's androgenicity relative to testosterone by decreasing its affinity for 5α-reduction, but does not eliminate androgenic effects at practical doses.
Methandienone is a strong aromatase substrate — it converts to 17α-methylestradiol, a potent estrogen. This conversion produces the water retention, blood pressure elevation, and gynecomastia risk that require aromatase inhibitor management on any methandienone cycle. The estrogenic load at 30–50 mg/day is substantial and responds well to anastrozole at 0.25–0.5 mg every other day, titrated to bloodwork.
Plasma half-life is approximately 3–6 hours, which is short for an oral AAS. This requires split dosing to maintain stable blood levels throughout the day — three doses spread across morning, midday, and evening are standard. Some users take all or most of the dose pre-workout to concentrate the strength peak, accepting lower blood levels during the rest of the day. Both approaches work; the split-dose method produces more consistent nitrogen retention and anabolic signaling across a 24-hour window.
What Methandienone Does
Methandienone produces its anabolic effects through androgen receptor activation, with several downstream mechanisms contributing to the rapid and pronounced nature of the response:
- Nitrogen retention — methandienone produces one of the strongest nitrogen retention effects of any oral AAS. A positive nitrogen balance is the biochemical prerequisite for net muscle protein accretion; methandienone shifts nitrogen balance strongly positive within days of the first dose. This is the primary driver of rapid early mass gains.
- Glycogenolysis enhancement — methandienone improves the efficiency of glycogen utilization in muscle, producing a rapid and pronounced increase in strength and training performance independent of protein synthesis changes. Strength gains with methandienone often appear in the first week, before significant protein accretion has had time to occur — glycogenolysis enhancement explains this early strength effect.
- Androgen receptor activation and protein synthesis — direct AR activation in muscle tissue upregulates the rate of protein synthesis, driving muscle hypertrophy over the course of the cycle. This is the mechanism responsible for the sustained mass gains across the 4–6 week window.
- SHBG reduction — methandienone reduces sex hormone-binding globulin, increasing the free fraction of other androgens in the bloodstream. This is particularly relevant when methandienone is used as a kickstart alongside a testosterone base — the free testosterone available for AR activation is amplified during the first weeks when the long-ester testosterone is still building to effective levels.
Water retention and "wet" gains: a portion of the mass gained on methandienone is intramuscular water and glycogen — not contractile protein. This is dose-dependent and E2-dependent; controlled aromatase inhibitor use reduces it. Water-related gains reverse after the cycle ends. Structural muscle gains from protein accretion persist post-cycle if training and nutrition are maintained.
Who It Is For
Methandienone at 10 mg/tab is suited to users for whom dose precision is a priority — whether that means starting low on a first cycle, managing side effects with granular adjustments, or running lower-dose Dianabol protocols where 20 mg tablets would force half-tablet splitting.
It is most appropriate for:
- First Dianabol cycle users — starting at 20–30 mg/day (2–3 tabs) and stepping up to 40–50 mg if the dose is well tolerated gives meaningful data points that a 50 mg single-tab format cannot provide. Beginning at the lowest effective dose and confirming individual estrogen response, blood pressure behavior, and hepatic tolerance before going higher is a risk-reduction approach that the 10 mg format directly enables.
- Low-dose Dianabol protocols — not all methandienone use targets maximum mass. Some users run 20–30 mg/day as a cycle enhancer alongside a testosterone base — enough to produce SHBG reduction, nitrogen retention benefits, and training performance improvement without the pronounced water retention of 50–80 mg doses. This lower-dose approach is only cleanly executable in 10 mg increments.
- Fine-tuning around side effects — if blood pressure rises or E2 becomes difficult to manage at 40 mg/day, stepping down to 30 mg rather than 20 mg is an option the 10 mg tablet provides. Users with variable individual sensitivity to aromatization or androgenic sides benefit from the 10 mg step-size.
Choose a different format when: the target dose is a clean 20 mg or 40 mg daily — Methanabol 20 covers these with one or two tablets and is more convenient at those specific doses. At 50 mg/day or above with no intent to adjust, Methanabol 50 reduces tablet count. The 10 mg format is optimal when flexibility and precision are the actual requirement.
Methanabol vs Alternatives
| Compound | Key Differences | Choose Methanabol 10 When | Choose Alternative When |
|---|---|---|---|
| Methanabol 10 British Dragon |
Methandienone 10 mg/tab; finest dose granularity in the BD Dianabol range; 10 mg steps from 10 to 100+ mg/day; full methandienone pharmacology at each increment | Precise titration is required; first Dianabol cycle; low-dose (20–30 mg) protocol; side effect management by dose step-down | — |
| Methanabol 20 British Dragon |
Methandienone 20 mg/tab; most practical format for standard 20–60 mg/day doses; 1–3 tablets cover the full working range; fewest tablets per day at standard doses | Target dose is 20, 40, or 60 mg/day; no fine-tuning needed; convenience at standard dosing range is priority | Starting below 20 mg, or needing 10 mg adjustments → Methanabol 10 |
| Methanabol 50 British Dragon |
Methandienone 50 mg/tab; high-dose convenience format; single tablet covers the full standard daily dose; minimal tablet count; least flexible for dose adjustment | Experienced user at a confirmed 50 mg/day with no need for adjustment; convenience at high doses is the priority | Dose flexibility needed or target dose below 50 mg → Methanabol 10 or 20 |
| Boldabol 200 British Dragon |
Boldenone undecylenate; injectable; slow-building anabolic with lower aromatization; lean, dry mass over a longer cycle (12–16 weeks); no hepatotoxicity; fundamentally different risk/benefit profile | Fast mass and strength gains needed within weeks; oral format preferred; kickstart role on a testosterone cycle | Lean, dry mass over a long cycle with lower side effect burden; injectable acceptable → Boldabol 200 |
Combinations
| Goal | Stack | Why It Works |
|---|---|---|
| Classic mass cycle kickstart | Methanabol 10 (30–50 mg/day, weeks 1–4) + Testabol Enanthate BD (500 mg/wk, weeks 1–12) + Anastrozole BD (0.25–0.5 mg EOD throughout) | Testabol Enanthate takes 3–4 weeks to build to effective blood levels. Methanabol fills that window with immediate mass and strength gains, while also reducing SHBG and increasing free testosterone bioavailability. By the time the Dianabol is discontinued, the enanthate is at full working levels and takes over. The 10 mg format allows starting at 30 mg and stepping to 40–50 mg after the first week if response is good. |
| Low-dose cycle enhancer | Methanabol 10 (20–30 mg/day throughout) + Boldabol 200 BD (400–600 mg/wk, 12–14 weeks) + Anastrozole BD (0.25 mg EOD, adjusted to bloodwork) | Boldabol produces slow, lean mass with low aromatization. Adding low-dose methandienone (20–30 mg) accelerates early results, enhances nitrogen retention, and provides glycogenolysis-driven strength improvement without the heavy water and estrogenic load of a 50+ mg Dianabol protocol. The 10 mg tablet makes the 20–30 mg range precise and straightforward to maintain. |
| First cycle — controlled entry | Methanabol 10 (20 mg/day weeks 1–2 → 30 mg/day weeks 3–4 if tolerated) + Testabol Enanthate BD (300–400 mg/wk) + Anastrozole BD (0.25 mg EOD) + Liv52 (throughout) | For users running Dianabol for the first time, starting at 20 mg/day for two weeks establishes a baseline — how E2 responds, how blood pressure trends, how the liver handles the oral load — before stepping to 30 mg. The 10 mg format is the only one that makes this stepwise approach practical without tablet splitting. |
Side Effects & Management
| What May Occur | Background | How to Handle It |
|---|---|---|
| Estrogen-related: water retention, gynecomastia risk, blood pressure | Methandienone is among the most estrogenic oral AAS — it converts to 17α-methylestradiol, which is more potent than estradiol at the estrogen receptor. Elevated E2 drives intracellular water retention, increases blood pressure, and in predisposed users creates nipple sensitivity and gynecomastia. These effects are dose-dependent and directly manageable with an aromatase inhibitor. Running methandienone without an AI is not recommended at any dose above 20 mg/day. | Aromatase inhibitor: Anastrozole Tablets BD at 0.25 mg EOD as a starting point — adjust based on E2 bloodwork. Start the AI with the first Dianabol dose; do not wait for symptoms. Blood pressure: Amlip (amlodipine) if readings exceed 135/85 mmHg on two consecutive checks. |
| Hepatotoxicity — elevated liver enzymes | 17α-alkylation makes methandienone hepatotoxic. ALT and AST elevations occur during any methandienone cycle — the degree correlates with dose and duration. At 30–50 mg/day for 4–6 weeks, enzyme elevation is expected but typically reversible after discontinuation in healthy users. Cycles exceeding 6 weeks or doses exceeding 80 mg/day carry meaningfully greater hepatic risk. Alcohol use during a methandienone cycle significantly compounds the hepatic load. | Liver support throughout the cycle: Liv52. Strict 6-week cycle cap. Avoid all alcohol. Run liver enzyme labs (ALT/AST) at baseline and mid-cycle. Any elevation above 3× upper limit of normal warrants immediate dose reduction or discontinuation. |
| Androgenic effects — acne, hair loss, oily skin | Despite the 1,2-double bond moderating 5α-reduction, methandienone retains meaningful androgenicity in skin and sebaceous tissue. Users predisposed to androgenetic alopecia may experience accelerated hair loss; acne, particularly on the back and shoulders, is common at doses of 40+ mg/day. Severity is individual and strongly dose-dependent. | Cystic or persistent acne: Isotroin (isotretinoin). Hair loss in genetically predisposed users is a structural property of the androgen class at these doses — dose reduction is the primary mitigation. |
| Lipid disruption — HDL suppression, LDL elevation | Methandienone produces a significant lipid profile shift: HDL drops and LDL rises. Oral 17α-alkylated compounds have a more pronounced lipid impact than injectable AAS at equivalent doses because of hepatic first-pass effects on lipoprotein metabolism. At 30–50 mg/day for 4–6 weeks, lipid changes are reversible post-cycle but require monitoring during use. | Lipid panel at baseline and mid-cycle (week 3). Elevated LDL above 130 mg/dL: Atorlip (atorvastatin). Omega-3 supplementation supports HDL. Minimize dietary saturated fat during the cycle. |
| HPG axis suppression | Methandienone suppresses LH and FSH through negative feedback at the hypothalamus and pituitary. At 30–50 mg/day for 4–6 weeks, suppression is significant and endogenous testosterone production effectively stops during the cycle. Recovery is generally good in healthy users following proper PCT, but the suppression window must be bridged by exogenous testosterone if methandienone is used as a standalone oral. | Always run a testosterone base alongside methandienone if the cycle extends beyond 4 weeks — even a low TRT dose (200 mg/wk Testabol Enanthate) prevents the hypogonadal trough from suppression. PCT (see below) follows the end of the entire cycle. |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| ALT / AST (liver enzymes) | Baseline before starting; week 3 mid-cycle; 4 weeks post-cycle | ALT and AST within 2× upper limit of normal during use. Any result above 3× ULN: reduce dose immediately; above 5× ULN: discontinue. Confirm normalization post-cycle — persistent elevation warrants further evaluation. |
| Estradiol (E2) | Baseline; week 2–3 on cycle; adjust AI dose accordingly | Target E2: 20–40 pg/mL on cycle. Below 15 pg/mL indicates AI overcorrection — reduce anastrozole frequency. Above 60 pg/mL with water retention or nipple sensitivity: increase AI dose. Methandienone's 17α-methylestradiol metabolite is not captured by all E2 assays — use a sensitive estradiol assay for the most relevant result. |
| Lipid panel (HDL / LDL / total cholesterol) | Baseline; week 3; 6 weeks post-cycle | HDL should stay above 35 mg/dL; LDL below 130 mg/dL. Oral methandienone will push both in the wrong direction — mid-cycle check confirms the magnitude and determines whether lipid support is needed. |
| Hematocrit / CBC | Baseline; mid-cycle | Hematocrit below 52%. Methandienone can stimulate erythropoiesis, particularly when stacked with testosterone. Elevated hematocrit raises blood viscosity and cardiovascular risk. |
| Blood pressure | Weekly during the methandienone window | Target below 130/80 mmHg. Estrogenic water retention and increased RBC mass both contribute to BP elevation on a Dianabol cycle. Weekly monitoring allows early intervention — Amlip before the cycle if the user has a history of on-cycle BP issues. |
| LH + FSH | Baseline; 4 weeks post-PCT | Confirm suppression depth at baseline and recovery at 4 weeks post-PCT. LH and FSH should return to pre-cycle range within 4–6 weeks of completing a standard PCT protocol following a 4–6 week Dianabol cycle. |
PCT — Post-Cycle Therapy
Methandienone suppresses the HPG axis fully at practical doses. PCT begins after the longest-ester compound in the cycle clears — if methandienone is used as a kickstart alongside Testabol Enanthate, PCT timing is set by the enanthate ester (start PCT approximately 2 weeks after the last injection), not by the Dianabol discontinuation date. If methandienone is used alone with only a short-ester testosterone or as a true standalone, PCT can begin 3–5 days after the last tablet.
| Product | Role |
|---|---|
| Clomiphene Tablets BD | 50 mg/day weeks 1–2, then 25 mg/day weeks 3–4. Primary LH/FSH stimulant — acts at the pituitary to restore gonadotropin output. Standard for all AAS PCT following a suppressing oral or injectable cycle. |
| Tamoxifen Tablets BD | 20 mg/day weeks 1–2, then 10 mg/day weeks 3–4. SERM at hypothalamic level — restores GnRH pulse frequency. Run alongside Clomiphene for the full 4 weeks. Tamoxifen also provides gynecomastia protection during the PCT window if E2 remains elevated in early recovery. |
Practical Summary
- Never run without an AI: methandienone converts to 17α-methylestradiol at meaningful rates at any practical dose above 20 mg/day. Have anastrozole on hand before the first tablet; start it with day one. Water retention, blood pressure, and gynecomastia risk are all directly controlled by E2 management — the AI is not optional.
- Liver support from day one, 6-week hard cap: Liv52 throughout the cycle, zero alcohol. The 6-week ceiling on 17α-alkylated orals exists for a reason — hepatic enzyme elevation is cumulative over the cycle duration. A 4-week Dianabol protocol carries meaningfully less hepatic burden than a 6-week one at the same dose.
- Split the dose three times daily: the 3–6 hour half-life makes once-daily dosing pharmacologically suboptimal. Morning, midday, and evening dosing maintains stable blood levels and sustained anabolic signaling. Pre-workout front-loading is an alternative for strength peaking but sacrifices 24-hour coverage.
- Start at 20–30 mg and earn your way up: the 10 mg format's key benefit is the ability to establish a baseline response before committing to higher doses. First-time users should run two weeks at 20–30 mg, check blood pressure and symptoms, then decide whether to step up.
- Always run a testosterone base for cycles over 4 weeks: methandienone suppresses endogenous testosterone production fully. A cycle longer than 4 weeks without exogenous testosterone creates a hypogonadal environment that impairs recovery, libido, and wellbeing. Even a low dose of Testabol Enanthate prevents this.
- PCT timing is set by the longest ester in the stack: if methandienone is the only compound, begin PCT 3–5 days after the last tablet. If stacked with a long-ester injectable, wait for the injectable to clear before starting SERMs — starting PCT too early while long-ester androgens are still active reduces its effectiveness.
Methanabol 10 remains one of the most practical formats for controlled methandienone use — the 10 mg unit provides the flexibility that higher-dose tablets cannot match. Whether the goal is a first Dianabol cycle with careful stepwise titration, a low-dose mass enhancement alongside a longer injectable base, or fine-grained side effect management on an established protocol, the granular dose control of the 10 mg tablet is a genuine functional advantage. steroidwarehouse.com carries the full British Dragon Methanabol range for users across all experience levels.
References
| Source | Description | Link |
|---|---|---|
| New England Journal of Medicine / PubMed | Bhasin et al. 1996 — randomized controlled trial evaluating 600 mg/week testosterone enanthate in healthy men with and without resistance training; demonstrated significant increases in fat-free mass, muscle size, and strength, establishing the anabolic effects of supraphysiologic testosterone administration | Bhasin S, et al. (1996) ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — clinical reference on synthetic testosterone-derived anabolic-androgenic steroids, androgen receptor activity, oral and injectable forms, adverse effect profiles, misuse patterns, and monitoring considerations | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — comprehensive overview of testosterone, dihydrotestosterone, androgen receptor signaling, HPG-axis regulation, synthetic androgen pharmacology, aromatization, and endocrine suppression associated with exogenous androgen use | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
| British Journal of Pharmacology / PubMed | Kicman AT 2008 — comprehensive review of anabolic-androgenic steroid pharmacology; covers androgen receptor binding, steroid metabolism, structural modification, ester pharmacokinetics, anabolic and androgenic mechanisms, detection methods, and adverse effects associated with AAS use | Kicman AT (2008) ↗ |
| Sports Medicine / PubMed | Hartgens F & Kuipers H 2004 — review of androgenic-anabolic steroid effects in athletes; covers strength and bodyweight changes, body composition, erythropoiesis, lipid profiles, cardiovascular effects, endocrine suppression, hepatic effects, and psychological considerations | Hartgens F & Kuipers H (2004) ↗ |
What is Methanabol?
Methanabol is an oral anabolic steroid (Methandienone) for rapid muscle growth; see What is Methanabol. It's potent—consult professionals for safe use.
What does Methanabol do?
It promotes muscle mass, strength, and recovery; see What Does Methanabol Do. It enhances performance—monitor with labs.
How long does Methanabol stay in your system?
Detectable for ~4-6 weeks; see How Long Does Methanabol Stay in Your System. Monitor with professional guidance.
How do I take Methanabol?
20-50 mg/day for men, 5-10 mg/day for women, split into 2-3 doses; see How to Take Methanabol. Start low—consult professionals for dosing.
How to cycle Methanabol?
4-6 weeks, 20-40 mg/day, PCT after 1-2 days; see How to Cycle Methanabol. Stack with testosterone—consult professionals for protocols.
How does Methanabol work?
Methanabol works by increasing protein synthesis and nitrogen retention, helping create a highly anabolic environment that supports muscle development and recovery.
What are the main benefits of Methanabol?
Commonly reported benefits include rapid muscle mass gains, enhanced strength, improved recovery, increased training intensity, and greater muscle fullness.
What are the possible side effects of Methanabol?
Potential side effects may include water retention, acne, elevated blood pressure, liver stress, changes in cholesterol levels, and suppression of natural testosterone production.
Related Products
